SCHEMBL7063456

SCHEMBL7063456

CCCCCCCCCCOC[C@@H](CO)OCCCCCCCCCC

nearest known ligand 0.64

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.63
LPAR1 Q92633 7/20 0.60
LPAR3 Q9UBY5 7/20 0.60
LPAR2 Q9HBW0 4/20 0.60
ALDH1A1 P00352 1/20 0.54
CNR1 P21554 1/20 0.54
CNR2 P34972 1/20 0.54
DNM1 Q05193 1/20 0.52
HTT P42858 2/20 0.52
TLR2 O60603 2/20 0.51
MEN1 O00255 1/20 0.50
THRB P10828 1/20 0.50
KMT2A Q03164 1/20 0.50
MAPT P10636 1/20 0.50
LPAR6 P43657 3/20 0.49
LPAR4 Q99677 3/20 0.49
LPAR5 Q9H1C0 3/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7060157 1.00 USP2 (0.63) USP2LPAR1LPAR3LPAR2ALDH1A1
SCHEMBL5249703 1.00 USP2 (0.63) USP2LPAR1LPAR3LPAR2ALDH1A1
SCHEMBL10561321 1.00 USP2 (0.63) USP2LPAR1LPAR3LPAR2ALDH1A1
SCHEMBL103054 1.00 USP2 (0.63) USP2LPAR1LPAR3LPAR2ALDH1A1
SCHEMBL2417250 1.00 USP2 (0.63) USP2LPAR1LPAR3LPAR2ALDH1A1
SCHEMBL25266425 1.00 USP2 (0.63) USP2LPAR1LPAR3LPAR2ALDH1A1
SCHEMBL15016340 1.00 USP2 (0.63) USP2LPAR1LPAR3LPAR2ALDH1A1
SCHEMBL7058701 1.00 USP2 (0.63) USP2LPAR1LPAR3LPAR2ALDH1A1
SCHEMBL7063486 1.00 USP2 (0.63) USP2LPAR1LPAR3LPAR2ALDH1A1
SCHEMBL3756748 1.00 USP2 (0.63) USP2LPAR1LPAR3LPAR2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119947709-A Lipid nanoparticles with nucleic acid supports 诺沃阿克有限责任公司 2025-05-06 CN disclosed
WO-2003049672-A2 METHODS AND COMPOSITIONS FOR TREATING FLAVIVIRUS-MEDIATED DISEASE MICROBIOTIX, INC. (US) 2003-06-19 WO disclosed
WO-2003041639-A2 METHODS AND COMPOSITIONS FOR TREATING ROTAVIRUS-MEDIATED DISEASE MICROBIOTIX, INC. (US) 2003-05-22 WO disclosed